<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349963/" ref="ordinalpos=95&amp;ncbi_uid=4003392&amp;link_uid=PMC3349963" image-link="/pmc/articles/PMC3349963/figure/F1/" class="imagepopup">Figure 1.  From: IL-13 <span class="highlight" style="background-color:">Signaling</span> in Liver Fibrogenesis. </a></div><br /><div class="p4l_captionBody"><b>(A)</b> Canonical and non-canonical IL-13 signaling in cells. IL-13 uses JAK/STAT6 pathway to transduce its canonical signaling in cells. In addition, IL-13 activates non-canonical STAT3, Erk1/2, etc., pathways in some settings. <b>(B)</b> Non-canonical signaling pathways of IL-13 play a critical role in liver fibrosis. IL-13 interacts with TGF-Î² signaling pathway to induce CTGF expression in HSCs via Erk1/2 pathway (Liu et al., 2011).</div></div>